Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News InnoCan Pharma Corporation INNPF


Primary Symbol: C.INNO

Healthcare Drug Manufacturers - Specialty & Generic
InnoCan Pharma Corporation operates as a pharmaceutical technology company in United States, Canada, Europe, and internationally. The company operates through two segments: Pharmaceuticals and Consumer Wellness. The company's Pharmaceutical segment engages in the development of drug delivery technologies for both human and animal health applications, based on advanced cannabinoids science. It... see more

Current News (CSE:INNO)

Innocan Pharma Announces Closing of Additional Debenture

Canada NewsWire 6 days ago

Innocan Pharma Announces Offering of an Additional Debenture to Tamar Innovest

Canada NewsWire 12 days ago

Innocan Pharma Reports 2025 Financial Results, with Revenues at US $26.6M

Canada NewsWire 12 days ago

Innocan Pharma Announces Closing of a Debenture to its Largest Shareholder, Tamar Innovest

Canada NewsWire March 16, 2026

Innocan Pharma Announces Offering of a Debenture to its Largest Shareholder, Tamar Innovest

Canada NewsWire March 11, 2026

FDA Center for Veterinary Medicine Grants Innocan a Fee Waiver in 2026 for the Third Consecutive Time

Canada NewsWire February 27, 2026

Innocan Pharma Announces LPT-CBD demonstrates Pain Relief over Placebo-Results from a randomized blinded clinical study in Dogs

Canada NewsWire February 9, 2026

Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering

Canada NewsWire January 27, 2026

Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering

Canada NewsWire January 2, 2026
View More News ››

Opinion & Analysis (CSE:INNO)

A Look into the Future of Chronic Pain Management

Research January 9, 2025
View More Opinion ››

Bullboard Posts (CSE:INNO)

CEO rating ..

Ghosting after hard efforts to get the attention of our family office. Not sure about mgmt .. 
Valorem - April 8, 2025

What do you think?

Interesting?
Tulsa123 - February 19, 2025

WAKE UP

this is a growth stock.  lots of news coming. do your dd .
longball44 - February 5, 2025

INNO

 we also own 60% of  BI Ski global ltd .  coming to north americian  markets   SOON    $$$
longball44 - February 5, 2025

InnoCan

I think InnoCan has established itself very well. Record sales are expected for 2024. See the news from January 29, 2025 at InnoCan.com....
Joel59 - February 4, 2025

RE:looks like

Hello, InnoCan deserves higher prices see the news from 29.01.2025 Excerpt from the news Yahoo!Finance HERZLIYA, Israel and CALGARY,&...
Joel59 - February 4, 2025
View more Bullboard ››

Pasofino Gold Limited

Pasofino Gold Limited

Pasofino Gold Limited, a Canada-based mineral exploration company, engages in the acquisition, exploration, and development ...
View More »

Podcasts